Although this gene has been confirmed to participate in metabolic reprogramming in liver and gastric cancers, its role in sepsis remains to be further validated, particularly whether it indirectly regulates inflammatory signals through the NF-κB or MAPK pathways (50, 51). Here, NFKB1 is linked to gastric cancer.